What is myopia?
Nothing is more important than the health and wellbeing of your child, now and in the future, you want to see your child thrive and that’s the key: seeing. You may have noticed your child struggling to see clearly at a distance, making it harder to concentrate at school and have a fulfilling experience at play. Your child may have myopia, also known as, short-sightedness.
Myopia is a global concern
An estimated 5 billion people, or half the global population, could be affected by myopia by 2050.1
Annual myopia progression rate is most rapid under 10 years of age. Significantly greater rates of progression can be seen especially in children with high myopia.
If left untreated, myopia can lead to lasting vision problems. But HOYA and Eye Care Professionals are on a mission to tackle myopia in children.
A breakthrough spectacle lens
This revolutionary spectacle lens based on patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology was developed in cooperation with The Hong Kong Polytechnic University in 2014. MiYOSMART is easy to fit, just like regular single vision lens. There are no limitations for the frame choice.
A revolutionary patented technology
With the exclusive non-invasive D.I.M.S. Technology, the lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus area and defocus area provides clear vision and manages myopia simultaneously.
Designed to fit a child’s active life
MiYOSMART comes with an easy-to-wipe special anti-reflective, durable coating. With its Eye Shield, young patients get the added assurance of an impact resistant material and UV protection.
MiYOSMART’s Eye Shield
- Impact resistant
- Thin and light
- Comes with UV protection
A child-friendly, safe and effective non-invasive method
During the 2 year clinical trial no adverse event was reported that would have led to discontinuation of the treatment.
The lens is a very effective method to manage myopia and can be fitted to a child at any age like regular single vision lens.
An award-winning, breakthrough ophthalmic lens, patented with D.I.M.S. technology
MiYOSMART’s efficacy is based on patent protected D.I.M.S. islands creating myopic defocus effect.
In 2018, the MiYOSMART lens won the Gold Prize, Grand Award & Special Gold Award Int’l Exhibition of Inventions of Geneva, Switzerland. In 2020, it won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.
Appreciated by parents
MiYOSMART has data-driven proof of its effectiveness, with more than 500K patients/wearers.
Parents are happy with the value for money.
They appreciated the Eye Care Professional 6 month protocol and follow-up actions.